Literature DB >> 15930778

Evaluation of the moisture sorption behaviour of several excipients by BET, GAB and microcalorimetric approaches.

Robert Roskar1, Vojko Kmetec.   

Abstract

Moisture content of solid-state pharmaceutical products is one of the main factors that affect drug stability, therefore suitable sorption studies need to be performed to assure drug quality throughout their shelf life. The Brunauer-Emmett-Teller (BET) and the Guggenheim-Anderson-de Boer (GAB) models are usually used for this purpose. Using gravimetrically obtained data, both methods were applied in the present work to evaluate the sorption characteristics of several excipients. Microcalorimetric analysis was also performed in order to evaluate the interaction between water and the substances. The results of these experiments show excellent agreement between data and the BET model up to 55% RH and the GAB model over the entire humidity range, confirmed by high values of the statistical determination coefficients. Furthermore, microcalorimetric measurements suggested that the hygroscopicity of solid materials could be estimated approximately using this approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930778     DOI: 10.1248/cpb.53.662

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.

Authors:  Kenneth Craig Waterman
Journal:  AAPS PharmSciTech       Date:  2011-07-12       Impact factor: 3.246

2.  Comparative Study of Powder Carriers Physical and Structural Properties.

Authors:  Klára Kostelanská; Barbora Blahová Prudilová; Sylva Holešová; Jakub Vlček; David Vetchý; Jan Gajdziok
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

3.  The effect of water on the solid state characteristics of pharmaceutical excipients: Molecular mechanisms, measurement techniques, and quality aspects of final dosage form.

Authors:  Gergely Szakonyi; Romána Zelkó
Journal:  Int J Pharm Investig       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.